Johnson & Johnson, the world’s largest maker of health-care products, said it expects growth to slow or halt this year, a warning as the rest of health-care sector prepares to give 2019 guidance in the coming weeks.
The company’s shares fell 1.8 percent Tuesday morning after saying that revenue this year will grow somewhere between 0 and 1 percent -- potentially worse when the strong dollar is factored in. While the company often tops the targets it sets for itself, the 2019 goal pales in comparison to its projections a year ago for sales growth of almost 2 percent.
